Gerald E. Quirk
VP,Cor. Affairs & Gnrl Counsel, INFINITY PHARMACEUTICALS, INC.
Companies
- Syros Pharmaceuticals, Inc.General counsel Sep 29, 2016 to Nov 20, 20241
- Eledon Pharmaceuticals, Inc.General counsel May 28, 2015 to Dec 17, 20152
- INFINITY PHARMACEUTICALS, INC.VP,Cor. Affairs & Gnrl Counsel Jan 7, 2010 to Jan 9, 20123
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Syros Pharmaceuticals, Inc.0 shares4Nov 19, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 19, 2024Sold 46,657 shares at $0.22 of Syros Pharmaceuticals, Inc.4
- Sep 30, 2024Shares withheld for tax 3,100 shares at $2.10 of Syros Pharmaceuticals, Inc.5
- Sep 30, 2024Exercised options 10,000 shares of Syros Pharmaceuticals, Inc.5
- Mar 28, 2024Shares withheld for tax 7,046 shares at $5.59 of Syros Pharmaceuticals, Inc.6
- Mar 27, 2024Exercised options 22,500 shares of Syros Pharmaceuticals, Inc.6
- Oct 19, 2023Shares withheld for tax 6,897 shares at $2.10 of Syros Pharmaceuticals, Inc.7
- Oct 11, 2023Exercised options 22,500 shares of Syros Pharmaceuticals, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Oct 2, 2024
- 6SEC EDGARForm 4 filed Apr 2, 2024
- 7SEC EDGARForm 4 filed Oct 20, 2023